In a significant development, President Donald Trump has decided to terminate the United States’ funding to the Gavi vaccine alliance, a global initiative supported by the World Health Organization (WHO). This move marks a continuation of the longstanding conflict between the Trump administration and the UN health body. Gavi plays a crucial role in financing vaccine distribution worldwide, particularly in low-income countries, making this decision impactful on global health efforts.
The US has been one of the largest contributors to Gavi, which aims to improve access to immunization and combat infectious diseases. By cutting off funding, the Trump administration signals a shift in its approach to international health cooperation, potentially affecting vaccine availability and global pandemic preparedness. This action also reflects broader skepticism within the administration regarding multilateral organizations.
Meanwhile, global health experts warn that the withdrawal of US support could undermine ongoing vaccination campaigns and delay progress in controlling preventable diseases. The decision may also strain diplomatic relations with allies who back WHO initiatives. As the world continues to face health challenges, the funding cut raises concerns about the future of international collaboration in vaccine development and distribution.
